Quantitative Studies Next Step to Understand Clinical Meaningfulness in Metastatic Breast Cancer Care
More research on clinical meaningfulness is on the way, according to Stephanie Graff, M.D., FACP, FASCO.
Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, explained that this study was just phase one of several to come.
For the next phase of research, her and her team plan to shift towards quantitative studies to examine how often, when and what tools are needed to facilitate conversations about clinical meaningfulness between patients and caregivers.
“I think that gathering all the qualitative work is going to help us build the set of data that informs the more quantitative work for a much broader group of data,” Graff said.
Graff said that patient care will continue to be at the center of the next phases of research.
“This is about a patient being able to effectively go to their doctor and say, ‘this is what's important to me,’ or the physician having the right language toolkit to say, ‘this is going to extend your life with median improvement in overall survival of 3.2 months which is an improvement in progression-free survival of 34%.' How do we turn medical statistics into clinically meaningful dialog with patients?”
How Financial Toxicity Screening Can Be Incorporated Into Everyday Healthcare in America
November 15th 2024Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can also happen in generalized healthcare, according to Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Breast Cancer Patients Desire Early, Frequent Financial Screening
November 11th 2024Current financial screening procedures in the United States may need to change, according to recent research done by Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Patient Advocacy Groups and Caretaker Diversity in Metastatic Breast Cancer Research
October 22nd 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, shares the reasons why she chose to study metastatic breast cancer patients.
Read More
Differences in Defining 'Clinically Meaningful' in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More
